Aetna’s Target TGT Stock Holding History

Aetna’s Portfolio TGT Stock Details TGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-144,950	Closed	-$10.5M	–	7
2016 Q4	$10.5M	Buy	+144,950	New	+$10.5M	18.61%	4

Other funds holding TGT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Aetna's TGT Position: Q1 2017 in Review

Aetna sold out of Target (TGT) in Q1 2017, closing a stake of 144,950 shares — an estimated $10.5M sold.

Aetna first reported a position in TGT in Q4 2016 and held it in 1 quarter. The position peaked at $10.5M in Q4 2016. 1,067 funds tracked by Wall St. Rank hold TGT as of Q1 2017.

Aetna reported no remaining Target position as of Q1 2017 after selling out during the quarter.
Aetna sold 144,950 Target shares in Q1 2017, an estimated $10.5M.
Aetna first reported a position in Target in Q4 2016 and held it in 1 quarter.
Aetna's Target position peaked at $10.5M in Q4 2016.
1,067 funds tracked by Wall St. Rank held Target as of Q1 2017.

Based on Aetna's 13F filing for Q1 2017, filed 8 May 2017.